(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide

C66H121NO13 — CID 165261973

IUPAC(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide
SMILESCCCCCCCCC/C=C/CC/C=C/CC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCCC/C=C\CCCCCCCCCC
InChIInChI=1S/C66H121NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-34-36-38-40-42-44-46-48-50-58(71)67-54(55(70)49-47-45-43-41-39-37-35-33-20-18-16-14-12-10-8-6-4-2)53-77-65-63(76)61(74)64(57(52-69)79-65)80-66-62(75)60(73)59(72)56(51-68)78-66/h20-22,33,39,41,47,49,54-57,59-66,68-70,72-76H,3-19,23-32,34-38,40,42-46,48,50-53H2,1-2H3,(H,67,71)/b22-21-,33-20+,41-39+,49-47+
InChIKeyNLFGTPYFGMYTIX-CWCGAVOHSA-N
MW1136.69 g/mol
LogP12.34
Rot. Bonds53

About (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide

(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide (PubChem CID 165261973) has the molecular formula C66H121NO13 and a molecular weight of 1136.69 g/mol. Its IUPAC name is (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide.

Molecular Properties

Compound Name(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide
PubChem CID165261973
Molecular FormulaC66H121NO13
Molecular Weight1136.69 g/mol
Exact Mass1135.88
IUPAC Name(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide
SMILESCCCCCCCCC/C=C/CC/C=C/CC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCCC/C=C\CCCCCCCCCC
InChIInChI=1S/C66H121NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-34-36-38-40-42-44-46-48-50-58(71)67-54(55(70)49-47-45-43-41-39-37-35-33-20-18-16-14-12-10-8-6-4-2)53-77-65-63(76)61(74)64(57(52-69)79-65)80-66-62(75)60(73)59(72)56(51-68)78-66/h20-22,33,39,41,47,49,54-57,59-66,68-70,72-76H,3-19,23-32,34-38,40,42-46,48,50-53H2,1-2H3,(H,67,71)/b22-21-,33-20+,41-39+,49-47+
InChIKeyNLFGTPYFGMYTIX-CWCGAVOHSA-N
XLogP12.34
TPSA227.86 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds53
Heavy Atoms80
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001136.69
LogP ≤ 512.34
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide?
The IUPAC name of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide (CID 165261973) is (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide.
What is the SMILES notation for (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide?
The canonical SMILES for (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide is CCCCCCCCC/C=C/CC/C=C/CC/C=C/C(O)C(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)NC(=O)CCCCCCCCCCCCCCCCCCC/C=C\CCCCCCCCCC.
What is the InChIKey of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide?
The InChIKey is NLFGTPYFGMYTIX-CWCGAVOHSA-N. The full InChI is InChI=1S/C66H121NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-31-32-34-36-38-40-42-44-46-48-50-58(71)67-54(55(70)49-47-45-43-41-39-37-35-33-20-18-16-14-12-10-8-6-4-2)53-77-65-63(76)61(74)64(57(52-69)79-65)80-66-62(75)60(73)59(72)56(51-68)78-66/h20-22,33,39,41,47,49,54-57,59-66,68-70,72-76H,3-19,23-32,34-38,40,42-46,48,50-53H2,1-2H3,(H,67,71)/b22-21-,33-20+,41-39+,49-47+.
What are the key properties of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide?
(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide has a molecular weight of 1136.69 g/mol, XLogP of 12.34, 53 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydocosa-4,8,12-trien-2-yl]dotriacont-21-enamide is sourced from PubChem (CID 165261973), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).